25-hydroxycholesterol has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Fukazawa, H; Igarashi, Y; Noguchi, K; Tanaka, AR; Uehara, Y | 1 |
| Bai, B; Sato, H; Sugiura, H; Tanaka, T; Yamamoto, K | 1 |
| Broitman, SA; Cerda, SR; Wilkinson, J | 1 |
3 other study(ies) available for 25-hydroxycholesterol and Colonic Neoplasms
| Article | Year |
|---|---|
p38MAPK and Rho-dependent kinase are involved in anoikis induced by anicequol or 25-hydroxycholesterol in DLD-1 colon cancer cells.
Topics: Anoikis; Cell Line, Tumor; Colonic Neoplasms; Ergosterol; Humans; Hydroxycholesterols; p38 Mitogen-Activated Protein Kinases; rho-Associated Kinases; RNA Interference | 2013 |
Combined effect of 25-hydroxycholesterol and IL-1beta on IL-8 production in human colon carcinoma cell line (Caco-2).
Topics: Adenocarcinoma; Caco-2 Cells; Colonic Neoplasms; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydroxycholesterols; Interleukin-1beta; Interleukin-8; Osmolar Concentration; Promoter Regions, Genetic; RNA, Messenger | 2005 |
Regulation of cholesterol synthesis in four colonic adenocarcinoma cell lines.
Topics: Adenocarcinoma; Binding, Competitive; Blood; Cholesterol; Cholesterol, LDL; Colonic Neoplasms; Culture Media; Enzyme Inhibitors; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Receptors, LDL; Tumor Cells, Cultured | 1995 |